|
Gender (male:female)
|
0.33
|
0.567
| | | |
|
Age (year) (> 60: ≤ 60)
|
0.04
|
0.834
| | | |
|
PLT ((109/L)) (≤ 100: > 100)
|
0.11
|
0.742
| | | |
|
ALB (g/L) (≤ 35: > 35)
|
0.04
|
0.848
| | | |
|
TBIL (μmol/L) (> 17.1: ≤ 17.1)
|
3.48
|
0.062
| | | |
|
PT (s) (> 16: ≤ 16)
|
0
|
0.993
| | | |
|
AFP (ng/mL) (> 200: ≤ 200)
|
0.53
|
0.468
| | | |
|
Hepatitis (yes:no)
|
1.53
|
0.216
| | | |
|
Cirrhosis (yes:no)
|
0.66
|
0.416
| | | |
|
Tumor number (multiple:solitary)
|
18.8
|
< 0.001
|
2.058
|
1.386–3.057
|
< 0.001
|
|
Tumor size (cm) (> 5: ≤ 5)
|
14.4
|
< 0.001
|
1.584
|
1.079–2.325
|
0.019
|
|
MVI (yes: no)
|
8.1
|
0.006
|
1.703
|
1.301–1.965
|
0.008
|
|
Tumor differentiation (poor:others)
|
1.22
|
0.269
| | | |
|
Tumor location (non-subcapsular:subcapsular)
|
2.79
|
0.095
| | | |
|
Resection margin (cm) (≤ 1: > 1)
|
0.97
|
0.323
| | | |
|
Hemorrhage (mL) (> 400: ≤ 400)
|
7.6
|
0.006
|
1.361
|
0.896–2.066
|
0.149
|
|
ALBI grade (II:I)
|
3.46
|
0.063
| | | |
|
Follow-up interval (short:long)
|
1.03
|
0.311
| | | |
